The company attributed the profit decline to the rise in impairment losses and deferred taxes on unrealized profit.
Should the earnings be calculated according to Hong Kong's accounting principles, the company’s net profit will hit 101 million yuan, an increase of 1.62 percent year-on-year.
Sales revenue totaled 2.61 billion yuan, of which the chemical raw material drugs, preparations, commercial distribution, and chemical products businesses contributed 49.64 percent, 19.53 percent, 26.18 percent and 4.65 percent, respectively.
Total assets as of end 2010 hit 2.74 billion yuan, up 4.32 percent year-on-year. Net assets rose 2.62 percent to 1.68 billion yuan.
The company plans to distribute cash dividends of 0.5 yuan (including tax) for every 10 shares held. It expects to pay out a total of 22.87 million yuan.
No comments:
Post a Comment